Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Fetal and Maternal Repercussions of Gestational Diabetes After the Adoption of the Diagnostic Criteria Proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG): a Cohort Study
Verified date | July 2017 |
Source | University of Sao Paulo General Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Gestational diabetes (GDM) is the most common hormonal complication during pregnancy. Its occurrence implies an increased risk of maternal and fetal complications and, therefore, its diagnosis and treatment are extremely important. Since the adoption of the new diagnostic criteria proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) in 2010, an increasing number of cases of mild hyperglycemia have demanded follow-up and treatment. The need and benefit of treatment in these cases of mild hyperglycemia has been discussed worldwide. Women who have been diagnosed with GDM are at increased risk for type 2 DM in the years following gestation. Other factors (such as lipid profile, obesity, adipokine dosage) may also be related to the repercussions of GDM on the maternal-fetal binomial, since gestations with satisfactory glycemic control can also present complications related to the disease and increased risk of type 2 DM in the long term. The present study aims to investigate factors associated with the need for insulin use, the occurrence of perinatal complications, nutritional status, physical activity and weight retention one year after delivery and the postpartum diagnosis of type 2 DM 10 years after delivery in women diagnosed with GDM according to the current criteria suggested by the IADPSG.
Status | Enrolling by invitation |
Enrollment | 1400 |
Est. completion date | December 2030 |
Est. primary completion date | June 2030 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - single pregnancies - absence of glucose intolerance prior to gestation (defined by prior diagnosis of polycystic ovarian syndrome or fasting glycemia =100mg / dl or 2hr post-overload with 75g glucose = 140mg / dL or glycated hemoglobin = 5.7% previously to pregnancy) - absence of chronic use of glucocorticoids or antiretroviral drugs for HIV virus, given its diabetogenic effect and potential confounding - diagnosis of GDM according to diagnostic criteria proposed by the IADPSG, namely: initial fasting blood glucose = 92mg / dL OR oral glucose tolerance test of 75g with fasting = 92mg / dL or after1h = 180mg / dL or after 2h = 153mg / dL - Agreement with the informed consent term for patients who will be followed prospectively - Agreement with the free and informed consent term for recall and reassessment of the patients identified in the retrospective analysis of the data Exclusion Criteria: - loss to follow up during pregnancy |
Country | Name | City | State |
---|---|---|---|
Brazil | Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo | Sao Paulo |
Lead Sponsor | Collaborator |
---|---|
University of Sao Paulo General Hospital |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Occurrence of type 2 DM after GDM | To evaluate clinical, nutritional and laboratory factors as tools to predict the diagnosis of type 2 DM, carbohydrate intolerance or postpartum metabolic syndrome in women who had GDM | 10 years | |
Secondary | Need of insulin | To evaluate clinical and laboratory factors as tools to predict the need of insulin during pregnancy | during pregnancy | |
Secondary | Weight at birth | To evaluate clinical, ultrasonographic and laboratory factors as tools to predict weight at birth (grams) | during pregnancy and delivery | |
Secondary | Route of delivery | To evaluate clinical, ultrasonographic and laboratory factors as tools to predict the route of delivery | during pregnancy and delivery | |
Secondary | Neonatal Hypoglycemia | To evaluate clinical, ultrasonographic and laboratory factors as tools to predict neonatal hypoglycemia | during pregnancy and delivery | |
Secondary | Obesity in the offspring | To evaluate clinical, ultrasonographic and laboratory factors as tools to predict obesity in the offspring of women with GDM | 10 years | |
Secondary | Hypertension in the offspring | To evaluate clinical, ultrasonographic and laboratory factors as tools to predict hypertension in the offspring of women with GDM | 10 years | |
Secondary | Body composition | To assess the body composition of women with gestational diabetes during pregnancy, 6 months postpartum and one year postpartum | during pregnancy, 6 months postpartum and one year after delivery | |
Secondary | Physical activity | identify the level of daily physical activity of women with gestational diabetes during pregnancy, 6 months postpartum and one year postpartum | during pregnancy , 6 months postpartum and 1 year after delivery | |
Secondary | Eating habits | to verify the eating habits of women with gestational diabetes during pregnancy, 6 months postpartum and one year postpartum | during pregnancy, 6 months postpartum and 1 year after delivery | |
Secondary | Weight retention | To study association between levels of physical activity and dietary intake and the weight retention in women with gestational diabetes during pregnancy, 6 months postpartum and one year postpartum | during pregnancy, 6 months postpartum and 1 year after delivery | |
Secondary | Route of delivery vs physical activity | to study association between the level of physical activity in women with gestational diabetes during pregnancy and the route of delivery (cesarian or vaginal birth) | during pregnancy and delivery | |
Secondary | Route of delivery vs eating habits | to study association between the eating habits in women with gestational diabetes during pregnancy and the route of delivery (cesarian or vaginal birth) | during pregnancy and delivery | |
Secondary | Fetal weight at birth vs physical activity | to study association between physical activity in women with gestational diabetes during pregnancy and the fetal weight at delivery (grams) | during pregnancy and delivery | |
Secondary | Fetal weight at birth vs eating habits | to study association between eating habits in women with gestational diabetes during pregnancy and the fetal weight at delivery (grams) | during pregnancy and delivery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |